Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats

被引:83
|
作者
Jose Zarzuelo, Maria [1 ]
Jimenez, Rosario [1 ,3 ]
Galindo, Pilar [1 ]
Sanchez, Manuel [1 ]
Nieto, Ana [4 ]
Romero, Miguel [1 ]
Maria Quintela, Ana [1 ]
Lopez-Sepulveda, Rocio [1 ]
Gomez-Guzman, Manuel [1 ]
Bailon, Elvira [1 ]
Rodriguez-Gomez, Isabel [2 ]
Zarzuelo, Antonio [1 ,5 ]
Galvez, Julio [1 ,5 ]
Tamargo, Juan [6 ]
Perez-Vizcaino, Francisco [6 ,7 ,8 ]
Duarte, Juan [1 ]
机构
[1] Univ Granada, Sch Pharm, Dept Pharmacol, E-18071 Granada, Spain
[2] Univ Granada, Sch Med, Dept Physiol, E-18071 Granada, Spain
[3] Ctr Biomed Res, Granada, Spain
[4] Anapath, Anat Pathol Lab, Granada, Spain
[5] Ciber Enfermedades Hepat & Digest, Madrid, Spain
[6] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain
[7] Ciber Enfermedades Resp, Madrid, Spain
[8] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain
关键词
PPAR beta/delta; spontaneously hypertensive rat; endothelial dysfunction; NADPH oxidase; regulators of G protein-coupled signaling proteins; PROTEIN-KINASE-C; ANGIOTENSIN-II; OXIDATIVE STRESS; FATTY-ACID; PPAR-ALPHA; KAPPA-B; EXPRESSION; ENDOTHELIN-1; HEART; HYPERTROPHY;
D O I
10.1161/HYPERTENSIONAHA.111.174490
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta) has been shown to improve insulin resistance and plasma high-density lipoprotein levels, but nothing is known about its effects in genetic hypertension. We studied whether the PPAR beta agonist GW0742 might exert antihypertensive effects in spontaneously hypertensive rats (SHRs). The rats were divided into 4 groups, Wistar Kyoto rat-control, Wistar Kyoto rat-treated (GW0742, 5 mg . kg(-1) . day(-1) by oral gavage), SHR-control, and SHR-treated, and followed for 5 weeks. GW0742 induced a progressive reduction in systolic arterial blood pressure and heart rate in SHRs and reduced the mesenteric arterial remodeling, the increased aortic vasoconstriction to angiotensin II, and the endothelial dysfunction characteristic of SHRs. These effects were accompanied by a significant increase in endothelial NO synthase activity attributed to upregulated endothelial NO synthase and downregulated caveolin 1 protein expression. Moreover, GW0742 inhibited vascular superoxide production, downregulated p22(phox) and p47(phox) proteins, decreased both basal and angiotensin II-stimulated NADPH oxidase activity, inhibited extracellular-regulated kinase 1/2 activation, and reduced the expression of the proinflammatory and proatherogenic genes, interleukin 1 beta, interleukin 6, or intercellular adhesion molecule 1. None of these effects were observed in Wistar Kyoto rats. PPAR beta activation, both in vitro and in vivo, increased the expression of the regulators of G protein-coupled signaling proteins RGS4 and RGS5, which negatively modulated the vascular actions of angiotensin II. PPAR beta activation exerted antihypertensive effects, restored the vascular structure and function, and reduced the oxidative, proinflammatory, and proatherogenic status of SHRs. We propose PPAR beta as a new therapeutic target in hypertension. (Hypertension. 2011;58:733-743.)
引用
收藏
页码:733 / U437
页数:23
相关论文
共 50 条
  • [21] Telmisartan Promotes Potential Glucose Homeostasis in Stroke-Resistant Spontaneously Hypertensive Rats via Peroxisome Proliferator-Activated Receptor γ Activation
    Omote, Yoshio
    Deguchi, Kentaro
    Kurata, Tomoko
    Yamashita, Toru
    Sato, Kota
    Hishikawa, Nozomi
    Abe, Koji
    CURRENT NEUROVASCULAR RESEARCH, 2015, 12 (01) : 91 - 97
  • [22] Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation
    Shi, Lijuan
    Shi, Lei
    Zhang, Hefang
    Hu, Zhijuan
    Wang, Chao
    Zhang, Donghui
    Song, Guangyao
    MOLECULAR MEDICINE REPORTS, 2013, 8 (02) : 439 - 445
  • [23] Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment
    Deplanque, D
    Gelé, P
    Pétrault, O
    Six, I
    Furman, C
    Bouly, M
    Nion, S
    Dupuis, B
    Leys, D
    Fruchart, JC
    Cecchelli, R
    Staels, B
    Duriez, P
    Bordet, R
    JOURNAL OF NEUROSCIENCE, 2003, 23 (15) : 6264 - 6271
  • [24] Targeted Genetic Disruption of Peroxisome Proliferator-Activated Receptor-δ and Colonic Tumorigenesis
    Zuo, Xiangsheng
    Peng, Zhanglong
    Moussalli, Micheline J.
    Morris, Jeffrey S.
    Broaddus, Russell R.
    Fischer, Susan M.
    Shureiqi, Imad
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 762 - 767
  • [25] Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer
    Peters, Jeffrey M.
    Kim, Dae J.
    Bility, Moses T.
    Borland, Michael G.
    Zhu, Bokai
    Gonzalez, Frank J.
    MOLECULAR CARCINOGENESIS, 2019, 58 (09) : 1612 - 1622
  • [26] Celecoxib inhibits acute edema and inflammatory biomarkers through peroxisome proliferator-activated receptor-γ in rats
    Houshmand, Gholamreza
    Naghizadeh, Bahareh
    Ghorbanzadeh, Behnam
    Ghafouri, Zahra
    Goudarzi, Mehdi
    Mansouri, Mohammad Taghi
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (12) : 1544 - 1550
  • [27] Irbesartan Prevents Metabolic Syndrome in Rats via Activation of Peroxisome Proliferator-Activated Receptor γ
    Takai, Shinji
    Jin, Denan
    Miyazaki, Mizuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 116 (03) : 309 - 315
  • [28] Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury
    Wang Cairui
    Zhou Guopeng
    Zeng Zeng
    CHINESE MEDICAL JOURNAL, 2014, 127 (11) : 2129 - 2137
  • [29] Peroxisome Proliferator-Activated Receptor-γ Contributes to the Inhibitory Effects of Embelin on Colon Carcinogenesis
    Dai, Yun
    Qiao, Liang
    Chan, Kwok Wah
    Yang, Mo
    Ye, Jieyu
    Ma, Juan
    Zou, Bing
    Gu, Qing
    Wang, Jide
    Pang, Roberta
    Lan, H. Y.
    Wong, Benjamin C. Y.
    CANCER RESEARCH, 2009, 69 (11) : 4776 - 4783
  • [30] Evidence Implicating Peroxisome Proliferator-Activated Receptor-γ in the Pathogenesis of Preeclampsia
    McCarthy, Fergus P.
    Drewlo, Sascha
    English, Fred A.
    Kingdom, John
    Johns, Edward J.
    Kenny, Louise C.
    Walsh, Sarah K.
    HYPERTENSION, 2011, 58 (05) : 882 - U447